Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Nephroplus Announces...

    Nephroplus Announces Acquires of DaVita Care India

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-11-06T11:00:37+05:30  |  Updated On 6 Nov 2018 11:00 AM IST
    Nephroplus Announces Acquires of DaVita Care India

    Banglore: NephroPlus, India’s largest dialysis care network and a trailblazer in redefining dialysis care in India announced the acquisition of DaVita Care India, part of DaVita Inc., a Fortune 500 company, and a leading provider of kidney care in India today.


    Under the terms of the agreement, which closed today, NephroPlus will acquire DaVita Care India’s network of 22 centres which serve more than 1,700 dialysis patients nationwide. With this acquisition, Nephroplus will further strengthen its servicing capacity as the dominant dialysis centre network and will have a presence in 18 states of India with 176 centres across 97 cities.


    “We are proud of our accomplishments in India and this deal is a reflection of the hard work and value creation delivered by our team,” said DaVita International CEO Robert Lang. “We remain excited about our future in the Asia Pacific and look forward to continuing our commitment to the region.”


    Vikram Vuppala, Founder and CEO, NephroPlus said: “NephroPlus was started 8 years back with a vision to enable people on dialysis across the world lead long, happy and productive lives. Today we serve over 12,000 patients on Dialysis through our network of 150+ clinics across 90+ cities in 18 states. With this acquisition, we have reaffirmed our strong commitment to redefine the dialysis delivery eco-system in India & abroad. We warmly welcome the clinical teammates, Nephrologist and Hospital partners of Davita India and importantly, all those getting dialyses at Davita centres into our network. We reinforce our commitment to further improving the standards of clinical care across the larger combined network”


    “This is an exciting time for NephroPus. This development offers immense opportunity to broaden our reach and provide our high-quality dialysis care at affordable prices to many more people on dialysis. We are excited to bring our proactive approach to clinical outcomes, no-comprise clinical quality and safety and guest-centric care to many more people on dialysis. We will be able to touch many more lives through this acquisition and showcase our core value of ‘Guest care comes first’ to more people on dialysis.” said Kamal Shah, Co-Founder and Director Patient Services. He has been on dialysis himself for over 21 years.


    affordable pricesDaVita Care Indiadialysis caredialysis care networkFortune 500 companykidney careNephroPlusVikram Vuppala

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok